Learn about COPD medications, including bronchodilators, steroids, and combination treatments. Understand how they work, their side effects, and ways to manage COPD effectively.

2025年6月12日，国家药监局（NMPA）正式批准瑞维那新吸入溶液的上市申请，用于慢性阻塞性肺病（COPD）的维持治疗，其也是全球首个每日一次、雾化给药的长效抗胆碱药物（LAMA）。为广大COPD患者提供强有力武器COPD是一种具有高发病率、高致残率和高致死率的慢性呼吸系统疾病。据估计，中国约有1亿人受COPD困扰，其中约43%的 ...

AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...

More than a million dollars is being allocated to Southwest Virginia to aid in the treatment of black lung disease. Morgan ...

Like many other major pharmaceutical companies, AstraZeneca is facing a series of patent cliffs for key treatments in its ...

Shyamali Dharmage grew up in rural Sri Lanka and was inspired to become a doctor after watching the impact of the local ...

Pulmonary Medicine : Welcome to Medscape Pulmonary Medicine, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles ...

Biotechnology firm Insilico Medicine said its new drug for lung disease, designed with the help of artificial intelligence (AI), showed positive results in the latest clinical trials, as the ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.